The biotech giant reported a bigger-than-expected quarterly loss. Finance chief James Mock attributed the loss to a scale down.
In its fourth-quarter earnings report, Moderna’s revenue was down substantially from 2023. Separately, media reports reveal anticipated cuts to the company’s digital team.
Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to ...
13h
Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 ...
Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
Shares of Moderna, along with other vaccine makers, dropped further this year as lawmakers advanced President Donald Trump's ...
"The suicides are a result of not knowing there is support, not being able to reach out for help to access the support that ...
2d
The Chief Minister, sharing details on his social media handles, said the initiative can help strike a better work-life ...
Mumbai on Wednesday reported first death from the Guillain-Barré Syndrome (GBS). A 53-year-old patient reportedly succumbed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback